The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Book Review
PreviousPrevious
Volume 359:1635 October 9, 2008 Number 15
NextNext

Clinical Management of Renal Tumors

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
Edited by Ronald M. Bukowski and Andrew C. Novick. 663 pp., illustrated. Totowa, NJ, Humana Press, 2008. $149. ISBN 978-1-58829-251-3.

Renal-cell carcinoma actually comprises a heterogeneous group of diseases with varying clinical presentations, all of which require a multidisciplinary approach to treatment, with contributions from urologists, pathologists, medical oncologists, radiologists, and nursing staff. The groundwork for the many advances made in renal-cell carcinoma over the past decade has its roots in two seminal laboratory discoveries. The first was the observation in 1979 that a translocation between the short arm of chromosome 3 and the long arm of chromosome 8 affected 8 of 10 members of a family with genes linked to a hereditary form of kidney cancer. The second was . . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.